BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32960052)

  • 1. Identification and Development of a New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[
    Yamasaki T; Zhang X; Kumata K; Zhang Y; Deng X; Fujinaga M; Chen Z; Mori W; Hu K; Wakizaka H; Hatori A; Xie L; Ogawa M; Nengaki N; Van R; Shao Y; Sheffler DJ; Cosford NDP; Liang SH; Zhang MR
    J Med Chem; 2020 Oct; 63(20):11469-11483. PubMed ID: 32960052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and preliminary studies of
    Zhang X; Zhang Y; Chen Z; Shao T; Van R; Kumata K; Deng X; Fu H; Yamasaki T; Rong J; Hu K; Hatori A; Xie L; Yu Q; Ye W; Xu H; Sheffler DJ; Cosford NDP; Shao Y; Tang P; Wang L; Zhang MR; Liang SH
    Theranostics; 2020; 10(24):11178-11196. PubMed ID: 33042277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[
    Zhang X; Kumata K; Yamasaki T; Cheng R; Hatori A; Ma L; Zhang Y; Xie L; Wang L; Kang HJ; Sheffler DJ; Cosford NDP; Zhang MR; Liang SH
    ACS Chem Neurosci; 2017 Sep; 8(9):1937-1948. PubMed ID: 28565908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 4-(2-fluoro-4-[
    Kumata K; Hatori A; Yamasaki T; Zhang Y; Mori W; Fujinaga M; Xie L; Nengaki N; Zhang MR
    Bioorg Med Chem; 2019 Feb; 27(3):483-491. PubMed ID: 30611634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain.
    Fujinaga M; Yamasaki T; Yui J; Hatori A; Xie L; Kawamura K; Asagawa C; Kumata K; Yoshida Y; Ogawa M; Nengaki N; Fukumura T; Zhang MR
    J Med Chem; 2012 Mar; 55(5):2342-52. PubMed ID: 22316010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-(Cyclopropylmethyl)-7-((4-(4-[
    Kumata K; Zhang Y; Ogawa M; Kurihara Y; Mori W; Hu K; Fujinaga M; Nengaki N; Zhang MR
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127555. PubMed ID: 32941990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis and evaluation of 5-methyl-N-(4-[(11)C]methylpyrimidin-2-yl)-4-(1H-pyrazol-4-yl)thiazol-2-amine ([(11)C]ADX88178) as a novel radioligand for imaging of metabotropic glutamate receptor subtype 4 (mGluR4).
    Fujinaga M; Yamasaki T; Nengaki N; Ogawa M; Kumata K; Shimoda Y; Yui J; Xie L; Zhang Y; Kawamura K; Zhang MR
    Bioorg Med Chem Lett; 2016 Jan; 26(2):370-374. PubMed ID: 26707390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosynthesis of N-(4-chloro-3-[(11)C]methoxyphenyl)-2-picolinamide ([(11)C]ML128) as a PET radiotracer for metabotropic glutamate receptor subtype 4 (mGlu4).
    Kil KE; Zhang Z; Jokivarsi K; Gong C; Choi JK; Kura S; Brownell AL
    Bioorg Med Chem; 2013 Oct; 21(19):5955-62. PubMed ID: 23978356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
    Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
    J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 1-(cyclopropylmethyl)-4-(4-[
    Ma Y; Kumata K; Yui J; Zhang Y; Yamasaki T; Hatori A; Fujinaga M; Nengaki N; Xie L; Wang H; Zhang MR
    Bioorg Med Chem; 2017 Feb; 25(3):1014-1021. PubMed ID: 28049619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and preliminary evaluation of 4-[18F]fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as a new positron emission tomography ligand for metabotropic glutamate receptor subtype 1.
    Yamasaki T; Fujinaga M; Yoshida Y; Kumata K; Yui J; Kawamura K; Hatori A; Fukumura T; Zhang MR
    Bioorg Med Chem Lett; 2011 May; 21(10):2998-3001. PubMed ID: 21470858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methyl-4-[11C]methylbenzamide for positron emission tomography imaging of metabotropic glutamate 1 receptor in monkey brain.
    Fujinaga M; Yamasaki T; Maeda J; Yui J; Xie L; Nagai Y; Nengaki N; Hatori A; Kumata K; Kawamura K; Zhang MR
    J Med Chem; 2012 Dec; 55(24):11042-51. PubMed ID: 23194448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomography.
    Toyohara J; Sakata M; Fujinaga M; Yamasaki T; Oda K; Ishii K; Zhang MR; Moriguchi Jeckel CM; Ishiwata K
    Nucl Med Biol; 2013 Feb; 40(2):214-20. PubMed ID: 23265669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of three novel radiotracers for imaging of metabotropic glutamate receptor subtype 2 in rat brain.
    Kumata K; Yamasaki T; Hatori A; Zhang Y; Mori W; Fujinaga M; Xie L; Okubo T; Nengaki N; Zhang MR
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3139-3143. PubMed ID: 28571823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 1-(2-[18F] fluoro-3-pyridyl)-4-(2-isopropyl-1-oxo- isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole, a PET ligand for imaging the metabotropic glutamate receptor type 1 in rat and monkey brains.
    Fujinaga M; Maeda J; Yui J; Hatori A; Yamasaki T; Kawamura K; Kumata K; Yoshida Y; Nagai Y; Higuchi M; Suhara T; Fukumura T; Zhang MR
    J Neurochem; 2012 Apr; 121(1):115-24. PubMed ID: 21668889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator.
    Wyss MT; Ametamey SM; Treyer V; Bettio A; Blagoev M; Kessler LJ; Burger C; Weber B; Schmidt M; Gasparini F; Buck A
    Neuroimage; 2007 Apr; 35(3):1086-92. PubMed ID: 17320417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
    Leurquin-Sterk G; Celen S; Van Laere K; Koole M; Bormans G; Langlois X; Van Hecken A; Te Riele P; Alcázar J; Verbruggen A; de Hoon J; Andrés JI; Schmidt ME
    J Nucl Med; 2017 Jan; 58(1):110-116. PubMed ID: 27469358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and preliminary evaluation of novel
    Sun JY; Kumata K; Chen Z; Zhang YD; Chen JH; Hatori A; Fu HL; Rong J; Deng XY; Yamasaki T; Xie L; Hu K; Fujinaga M; Yu QZ; Shao T; Collier TL; Josephson L; Shao YH; Du YF; Wang L; Xu H; Zhang MR; Liang SH
    Acta Pharmacol Sin; 2021 Mar; 42(3):491-498. PubMed ID: 32661351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
    Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.